Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2023

Apr 4, 2023

30442_dirs_2023-04-04_ba5cb636-9d99-436f-b661-d8d4fcc83e61.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2023-03-31

Reporting Person: McCarthy Cornelius P. III (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-31 Common Stock M 82 Acquired 82 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-31 Restricted Stock Unit $ M 82 Disposed Common Stock (82) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.